Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22McLendon%2C+Kristi%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22McLendon%2C+Kristi%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22McLendon%2C+Kristi%22&type=Person&sort=year
PubPharm (6)
1
Pharmacokinetic Profiles of a Proposed Biosimilar Ustekinumab (BFI-751) : Results From a Randomized Phase 1 Trial
enthalten in:
Clinical pharmacology in drug development
| 2023
von
Hausfeld, J.
|
Challand, R.
|
McLendon, K.
| +4
Wird geladen...
2
A randomized, double-blind, 3-arm, parallel study assessing the pharmacokinetics, safety, tolerability and immunogenicity of AVT04, an ustekinumab candidate biosimilar, in healthy adults
enthalten in:
Expert opinion on investigational drugs
| 2023
von
Wynne, C.
|
Hamilton, P.
|
McLendon, K.
| +9
Wird geladen...
3
Pharmacokinetic equivalence of CT-P39 and reference omalizumab in healthy individuals : A randomised, double-blind, parallel-group, Phase 1 trial
enthalten in:
Clinical and translational allergy
| 2022
von
Maurer, M.
|
Saini, S.
|
McLendon, K.
| +6
Wird geladen...
4
Pharmacokinetic equivalence of CT‐P39 and reference omalizumab in healthy individuals : A randomised, double‐blind, parallel‐group, Phase 1 trial
enthalten in:
Clinical and Translational Allergy
| 2022
von
Maurer, M.
|
Saini, S.
|
McLendon, K.
| +6
Wird geladen...
5
TROIKA-1 : A double-blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU-Herceptin® and US-Herceptin® in healthy male subjects
enthalten in:
Pharmacology research & perspectives
| 2021
von
Demarchi, M.
|
Coliat, P.
|
Mclendon, K.
| +10
Wird geladen...
6
TROIKA‐1 : A double‐blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU‐Herceptin® and US‐Herceptin® in healthy male subjects
enthalten in:
Pharmacology Research & Perspectives
| 2021
von
Demarchi, M.
|
Coliat, P.
|
Mclendon, K.
| +10
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
6
Aufsätze
6
E-Artikel
6
E-Ressourcen
Zeitschriftentitel
1
Clinical and Translational Allergy
1
Clinical and translational allergy
1
Clinical pharmacology in drug development
1
Expert opinion on investigational drugs
1
Pharmacology Research & Perspectives
1
Pharmacology research & perspectives
Alle anzeigen ...
weniger ...
Thema
4
Journal Article
4
biosimilar
3
Biosimilar Pharmaceuticals
3
Randomized Controlled Trial
3
pharmacokinetics
2
Clinical Trial, Phase I
2
FU77B4U5Z0
2
Research Support, Non-U.S. Gov't
2
Ustekinumab
2
ustekinumab
1
AVT04
1
Adalimumab
1
Antibodies
1
Antineoplastic Agents, Immunological
1
BFI-751
1
CT-P39
1
FYS6T7F842
1
Multicenter Study
1
NS0
1
P188ANX8CK
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
2
2022
2
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4
Englisch
Haven't found what you're looking for?
Wird geladen...